ListarInstituto de Biomedicina de Sevilla (IBIS) por materia "Relapse"
Mostrando ítems 1-1 de 1
-
Artículo
Impact of FLT3–ITD mutation status and its ratio in a cohort of 2901 patients undergoing upfront intensive chemotherapy: a PETHEMA registry study
(MDPI, 2022-11-22)FLT3–ITD results in a poor prognosis in terms of overall survival (OS) and relapse-free survival (RFS) in acute myeloid ...